phase 1 clinical trial unit Archives | WCCT Global

By WCCT2

In CRO, Phase 1 Clinical Trials

Posted August 25, 2020

Volunteer Safety in the Age of COVID-19

By WCCT2

In CRO, Phase 1 Clinical Trials

Posted June 30, 2020

Clinical Trial Blogs for Early Phase CROs: Effective Supplemental Vendor Management for Phase 1 Trials—Managing Vendor Relationships

By WCCT2

In CRO, Phase 1 Clinical Trials

Posted June 23, 2020

Clinical Trial Blogs for Early Phase CROs: Effective Supplemental Vendor Management for Phase 1 Trials—Qualifying Vendors

By WCCT2

In CRO, Phase 1 Clinical Trials

Posted June 16, 2020

Clinical Research Blog Series: Reducing Start-Up Time in Early Clinical Development—Reducing the Screening Window

By WCCT2

In CRO, Phase 1 Clinical Trials

Posted June 10, 2020

Clinical Research Blog Series: Reducing Start-Up Time in Early Clinical Development—Pre-Screening Volunteers

By WCCT2

In CRO, Phase 1 Clinical Trials

Posted June 9, 2020

Clinical Research Blog Series: Reducing Start-Up Time in Early Clinical Development—Functional and Flexible Staffing

By WCCT2

In Phase 1 Clinical Trials

Posted June 4, 2020

Clinical Research Blog Series: Reducing Start-Up Time in Early Clinical Development—Start-Up Agreements

By WCCT2

In CPU, Phase 1 Clinical Trials

Posted November 26, 2019

5 Strategies to Reduce the Cost of Phase 1 Clinical Trials

By WCCT2

In CPU, Phase 1 Clinical Trials

Posted October 23, 2019

10 Questions to Ask Clinical Phase 1 Units During Site Selection

It’s becoming more and more common for Sponsors and CROs to establish shortlists or preferred providers, even for Clinical Phase 1 Units. When this happens, the site selection and site [...]

By WCCT2

In CPU, Phase 1 Clinical Trials

Posted November 21, 2017

When Your Phase 1 Clinical Trial Unit Receives an FDA 483, What Then?

At some point or another, every Phase 1 clinical trial unit has or will receive a 483 from the FDA. Before we delve into what this means for a site, we’ll provide a bit of background. When are [...]